Integrative Analysis of Colonic Biopsies from Inflammatory Bowel Disease Patients Identifies an Interaction Between Microbial Bile Acid-inducible Gene Abundance and Human Angiopoietin-like 4 Gene Expression.


Journal

Journal of Crohn's & colitis
ISSN: 1876-4479
Titre abrégé: J Crohns Colitis
Pays: England
ID NLM: 101318676

Informations de publication

Date de publication:
18 Dec 2021
Historique:
pubmed: 3 6 2021
medline: 29 1 2022
entrez: 2 6 2021
Statut: ppublish

Résumé

Microbial-derived bile acids can modulate host gene expression, and their faecal abundance is decreased in active inflammatory bowel disease [IBD]. We analysed the impact of endoscopic inflammation on microbial genes involved in bile acid biotransformation, and their interaction with host transcriptome in the intestinal mucosa of IBD patients. Endoscopic mucosal biopsies were collected from non-inflamed and inflamed terminal ileum, ascending and sigmoid colon of IBD patients. Prediction of imputed metagenome functional content from 16S rRNA profile and real-time quantitative polymerase chain reaction [qPCR] were utsed to assess microbial bile acid biotransformation gene abundance, and RNA-seq was used for host transcriptome analysis. Linear regression and partial Spearman correlation accounting for age, sex, and IBD type were used to assess the association between microbial genes, inflammation, and host transcriptomics in each biopsy location. A Bayesian network [BN] analysis was fitted to infer the direction of interactions between IBD traits and microbial and host genes. The inferred microbial gene pathway involved in secondary bile acid biosynthesis [ko00121 pathway] was depleted in inflamed terminal ileum of IBD patients compared with non-inflamed tissue. In non-inflamed sigmoid colon, the relative abundance of bile acid-inducible [baiCD] microbial genes was positively correlated with the host Angiopoietin-like 4 [Angptl4] gene expression. The BN analysis suggests that the microbial baiCD gene abundance could affect Angptl4 expression, and this interaction appears to be lost in the presence of inflammation. Endoscopic inflammation affects the abundance of crucial microbial bile acid-metabolising genes and their interaction with Angptl4 in intestinal mucosa of IBD patients.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Microbial-derived bile acids can modulate host gene expression, and their faecal abundance is decreased in active inflammatory bowel disease [IBD]. We analysed the impact of endoscopic inflammation on microbial genes involved in bile acid biotransformation, and their interaction with host transcriptome in the intestinal mucosa of IBD patients.
METHODS METHODS
Endoscopic mucosal biopsies were collected from non-inflamed and inflamed terminal ileum, ascending and sigmoid colon of IBD patients. Prediction of imputed metagenome functional content from 16S rRNA profile and real-time quantitative polymerase chain reaction [qPCR] were utsed to assess microbial bile acid biotransformation gene abundance, and RNA-seq was used for host transcriptome analysis. Linear regression and partial Spearman correlation accounting for age, sex, and IBD type were used to assess the association between microbial genes, inflammation, and host transcriptomics in each biopsy location. A Bayesian network [BN] analysis was fitted to infer the direction of interactions between IBD traits and microbial and host genes.
RESULTS RESULTS
The inferred microbial gene pathway involved in secondary bile acid biosynthesis [ko00121 pathway] was depleted in inflamed terminal ileum of IBD patients compared with non-inflamed tissue. In non-inflamed sigmoid colon, the relative abundance of bile acid-inducible [baiCD] microbial genes was positively correlated with the host Angiopoietin-like 4 [Angptl4] gene expression. The BN analysis suggests that the microbial baiCD gene abundance could affect Angptl4 expression, and this interaction appears to be lost in the presence of inflammation.
CONCLUSIONS CONCLUSIONS
Endoscopic inflammation affects the abundance of crucial microbial bile acid-metabolising genes and their interaction with Angptl4 in intestinal mucosa of IBD patients.

Identifiants

pubmed: 34077506
pii: 6291049
doi: 10.1093/ecco-jcc/jjab096
pmc: PMC8684456
doi:

Substances chimiques

Angiopoietin-Like Protein 4 0
Bile Acids and Salts 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2078-2087

Subventions

Organisme : NIDDK NIH HHS
ID : U01 DK062423
Pays : United States
Organisme : NIH HHS
ID : U01DK062423
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

J Crohns Colitis. 2020 Jul 30;14(7):935-947
pubmed: 32016358
PLoS One. 2014 Dec 17;9(12):e115175
pubmed: 25517115
ISME J. 2012 Aug;6(8):1621-4
pubmed: 22402401
Nature. 2019 May;569(7758):655-662
pubmed: 31142855
J Clin Invest. 2014 Aug;124(8):3617-33
pubmed: 25003194
Int J Syst Evol Microbiol. 2000 May;50 Pt 3:971-978
pubmed: 10843034
Gastroenterology. 2011 Jul;141(1):227-36
pubmed: 21621540
Nat Biotechnol. 2013 Sep;31(9):814-21
pubmed: 23975157
Mol Aspects Med. 2017 Aug;56:54-65
pubmed: 28602676
Gut. 2013 Apr;62(4):531-9
pubmed: 22993202
Cell Host Microbe. 2020 Apr 8;27(4):659-670.e5
pubmed: 32101703
Sci Rep. 2017 Mar 13;7:44351
pubmed: 28287161
Nat Commun. 2021 Feb 18;12(1):1122
pubmed: 33602935
Gut Microbes. 2013 May-Jun;4(3):222-31
pubmed: 23549220
Nat Rev Immunol. 2016 May 27;16(6):341-52
pubmed: 27231050
Methods. 2018 Oct 1;149:49-58
pubmed: 29704662
Clin Chim Acta. 2003 May;331(1-2):127-34
pubmed: 12691873
Proc Natl Acad Sci U S A. 2014 May 20;111(20):7421-6
pubmed: 24799697
Gastrointest Endosc. 2004 Oct;60(4):505-12
pubmed: 15472670
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nature. 2020 Jan;577(7790):410-415
pubmed: 31875848
Appl Environ Microbiol. 2000 Mar;66(3):1107-13
pubmed: 10698778
BMC Genomics. 2019 Jun 25;20(1):517
pubmed: 31234773
Nat Biotechnol. 2017 Dec 8;35(12):1211
pubmed: 29220029
Gut Microbes. 2014;5(5):669-74
pubmed: 25483337
J Lipid Res. 2006 Feb;47(2):241-59
pubmed: 16299351
Gut. 2013 Sep;62(9):1306-14
pubmed: 22722618
Appl Environ Microbiol. 2006 Jul;72(7):5069-72
pubmed: 16820507
Curr Microbiol. 2013 Sep;67(3):286-92
pubmed: 23591474
Sci Rep. 2018 Mar 16;8(1):4736
pubmed: 29549283
Gut. 2017 Dec;66(12):2087-2097
pubmed: 27694142
Appl Environ Microbiol. 2018 Mar 19;84(7):
pubmed: 29330189
Diabetologia. 2018 Jun;61(6):1447-1458
pubmed: 29502266
Microbiome. 2019 May 15;7(1):75
pubmed: 31092280
Gastroenterology. 2019 Jun;156(8):2174-2189
pubmed: 30880022
Trends Endocrinol Metab. 2014 Mar;25(3):146-55
pubmed: 24397894
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13580-5
pubmed: 18757757
Mol Cell Biol. 2013 Apr;33(7):1303-16
pubmed: 23339868
Microbiome. 2019 Jan 23;7(1):9
pubmed: 30674356
Science. 2015 Jan 9;347(6218):170-5
pubmed: 25574022
Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Oct;1862(10 Pt A):1056-1067
pubmed: 28733267
Nat Microbiol. 2019 May;4(5):898
pubmed: 30971771
Genome Biol. 2011 Jun 24;12(6):R60
pubmed: 21702898
Genome Med. 2020 Jan 28;12(1):12
pubmed: 31992345
Nature. 2019 Dec;576(7785):143-148
pubmed: 31776512
Cell Metab. 2010 Dec 1;12(6):580-92
pubmed: 21109191
Nucleic Acids Res. 2000 Jan 1;28(1):33-6
pubmed: 10592175
Appl Environ Microbiol. 2018 May 1;84(10):
pubmed: 29549099
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Gut. 2019 Oct;68(10):1791-1800
pubmed: 30816855
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
Physiol Genomics. 2008 Mar 14;33(1):50-64
pubmed: 18056783
Appl Environ Microbiol. 2008 Aug;74(15):4719-26
pubmed: 18539794
N Engl J Med. 1987 Dec 24;317(26):1625-9
pubmed: 3317057
Bioinformatics. 2004 Jan 22;20(2):289-90
pubmed: 14734327
Clin Gastroenterol Hepatol. 2021 Feb;19(2):296-304.e3
pubmed: 32220613
Gut Microbes. 2020;11(2):158-171
pubmed: 31595814
Histochem Cell Biol. 2014 Apr;141(4):383-91
pubmed: 24141811

Auteurs

Cristian Hernández-Rocha (C)

Division of Gastroenterology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.
Zane Cohen Centre for Digestive Diseases, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.

Krzysztof Borowski (K)

Zane Cohen Centre for Digestive Diseases, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.

Williams Turpin (W)

Zane Cohen Centre for Digestive Diseases, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.
Department of Medicine, University of Toronto, Toronto, ON, Canada.

Melissa Filice (M)

Zane Cohen Centre for Digestive Diseases, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.

Shadi Nayeri (S)

Zane Cohen Centre for Digestive Diseases, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.

Juan Antonio Raygoza Garay (JA)

Zane Cohen Centre for Digestive Diseases, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.
Department of Medicine, University of Toronto, Toronto, ON, Canada.

Joanne M Stempak (JM)

Zane Cohen Centre for Digestive Diseases, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.

Mark S Silverberg (MS)

Division of Gastroenterology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.
Zane Cohen Centre for Digestive Diseases, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH